Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3780517

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
COc1cc2c(cc1OC)CN(CCc1ccc(-n3cc(COc4ccc([N+](=O)[O-])cc4)nn3)cc1)CC2
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL3780517
Phase Preclinical
Structure Type MOL
InChI Key NJDBWFRDMSHXBK-UHFFFAOYSA-N
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names

Molecular Properties

515.6
MW (Da)
4.37
ALogP
9
HBA
0
HBD
104.8
PSA (Ų)
0.23
QED
1
Ro5 Violations
10
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C28H29N5O5
MW 515.57
Aromatic Rings 4
Heavy Atoms 38
NP-Likeness -1.42

Activity Summary

IC50 2 meas. best 5.15

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
 IC50 5.15 5.15 7020.0 1
K562
CHEMBL385
 IC50 4.31 4.31 49220.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 7020.0 nM 5.15 Reversal of P-gp-mediated resistance to adriamycin in human K562/A02 cells asses... 27073052
K562 IC50 = 49220.0 nM 4.31 Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by... 27073052

Literature References

PubMed DOI Target Context # Activities
27073052 10.1016/j.bmc.2016.03.065 Unchecked 2
27073052 10.1016/j.bmc.2016.03.065 K562 1
27073052 10.1016/j.bmc.2016.03.065 ADMET 1

Data from ChEMBL 36 via Core Engine